- Abstract Number: 0511
Long-term Safety and Tolerability of Bimekizumab in Patients with Axial Spondyloarthritis and Psoriatic Arthritis: Results from Pooled Phase 2b/3 Studies
- Abstract Number: 1422
Long-Term Safety of Risankizumab in Patients with Psoriatic Disease: Integrated Analysis of Psoriasis and Psoriatic Arthritis Clinical Trial Data
- Abstract Number: 0679
Long-term Safety of Rituximab (Mabthera) in Granulomatosis with Polyangiitis (GPA) or Microscopic Polyangiitis (MPA): Rituximab Surveillance Study in VASculitis (RIVAS)
- Abstract Number: 0425
Long-term Safety of Rituximab in Rheumatoid Arthritis: A Systematic Review and Meta-analysis
- Abstract Number: 1533
Long-term Use of Rituximab in Systemic Sclerosis: A Real-life Italian Multicentre Study
- Abstract Number: 2325
Longitudinal ANA Titers in SLE and ANA-associated Rheumatic Diseases
- Abstract Number: 1229
Longitudinal Assessment of Self-reported Executive Function in Youth with Childhood-Onset Lupus
- Abstract Number: 1805
Longitudinal Changes in Serum Urate Associate Minimally with Changes in Daily Alcohol Intake
- Abstract Number: 2271
Longitudinal Changes in Type 1 & Type 2 SLE Activity
- Abstract Number: 2238
Longitudinal Effect of Guselkumab on Biomarkers of Inflammation and Cardiovascular Risk in Bionaive Patients with Active Psoriatic Arthritis and High Systemic Inflammatory Burden: Post-hoc Analysis of a Phase 3, Randomized, Double-blind, Placebo-Controlled Study
- Abstract Number: 0557
Longitudinal Evaluation of Cell-bound Complement Activation Products in Patients with SLE
- Abstract Number: 1429
Longitudinal Evaluation of the Novel Psoriatic Arthritis 5-Thermometer Scale (PsA-5Ts) Domains During Treatment with Guselkumab: Pooled Analysis of Three Phase 3, Randomized, Double-blind, Placebo-Controlled Studies
- Abstract Number: 0339
Longitudinal Glucocorticoid Toxicity in Rheumatic Disease Patients (LONG-TOX) and Associations with Quality of Life and Healthcare Resource Utilization: Interim Analysis from a Prospective Cohort
- Abstract Number: 2433
Longitudinal Multi-Omics Single Cell Analysis Reveals Abatacept Treatment Shifts Peripheral Lymphocyte Subpopulations in Seropositive RA with Reduction of Mature B Cells and Retention of Transitional and Naive B Cells
- Abstract Number: 1718
Longitudinal Quantification of Bone Erosions, Pulmonary Disease, Pain, Gait and Sarcopenia to Holistically Assess Decreased Ad Libitum Physical Activity and Effects of Exercise in the TNF-Transgenic Murine Model of Rheumatoid Arthritis
- « Previous Page
- 1
- …
- 95
- 96
- 97
- 98
- 99
- …
- 177
- Next Page »